Focal Atrial Tachycardia During Central Gemcitabine Administration
Gemcitabine has the capability to be directly arrhythmogenic. Centrally placed lines can abut the endocardium or vascular endothelial surface, which may counteract the intention to dilute therapeutic agents in large volumes of blood. A clear temporal relationship between symptom and medication should prompt consideration of the therapeutic as the causative agent.
Authors
- Shaumik Adhya (ORCID: https://orcid.org/0000-0001-5299-7402)
- Jaspal Singh Gill (ORCID: https://orcid.org/0000-0001-9246-5371)
- A. S. Sethi
- Andrew D’Silva (ORCID: https://orcid.org/0000-0002-8700-1545)
- Marco Pinto
- John Whitaker
Institutions
- Guy's and St Thomas' NHS Foundation Trust (GB)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106302
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39